[HTML][HTML] Magnesium Isoglycyrrhizinate Reduces the Target-Binding Amount of Cisplatin to Mitochondrial DNA and Renal Injury through SIRT3

X Wang, H Zhu, J Hu, H Li, S Guo, B Chen… - International Journal of …, 2022 - mdpi.com
… , cisplatin-DNA binding levels in liver and brain mitochondrial … lack of nucleotide excision
repair pathways in mitochondria, … decreases platinum–mtDNA adducts to protect renal tubular …

Cisplatin in the era of PARP inhibitors and immunotherapy

M Duan, S Leng, P Mao - Pharmacology & Therapeutics, 2024 - Elsevier
… both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) … Studies in Chinese hamster
ovary cells showed that cisplatin … indicates that formation of a cisplatin-DNA adduct (intra- or …

[HTML][HTML] Translesion activity of PrimPol on DNA with cisplatin and DNA–protein cross-links

EO Boldinova, AV Yudkina, ES Shilkin… - Scientific reports, 2021 - nature.com
… of cisplatinDNA adducts and their poor removal were reported for mitochondrial DNA as
compared to nuclear DNA … In this work, PrimPol preferentially incorporated two complementary …

[HTML][HTML] Revisiting the anti-cancer toxicity of clinically approved platinating derivatives

BN Forgie, R Prakash, CM Telleria - International Journal of Molecular …, 2022 - mdpi.com
… not due to preferential repair of transplatin lesions by nucleotide … for forming mitochondrial
DNA (mtDNA) adducts than nDNA … Furthermore, in Chinese hamster ovary cells, there is not …

Mitochondria participate in chemoresistance to cisplatin in human ovarian cancer cells

LX Zampieri, D Grasso, C Bouzin, D Brusa… - Molecular Cancer …, 2020 - AACR
CisplatinDNA adducts were quantified using the rat mAb CP9… E, Mitochondrial DNA content
normalized by nuclear DNAovarian cancer cell, preferentially cisplatin-resistant cells. Our …

[HTML][HTML] Cisplatin resistance in ovarian cancer: Classical outlook and newer perspectives

P Borkar, P Bhandari, S Yadav… - Biomedical and …, 2021 - biomedpharmajournal.org
… due to larger N7 guanine content of the mitochondrial DNA. … Cisplatin based combination
chemotherapy is preferred in … further reduction of cisplatin-DNA adducts formation. Reduction in …

Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy

PB Tchounwou, S Dasari, FK Noubissi… - Journal of …, 2021 - Taylor & Francis
… Citation10 The most common cisplatin-DNA adduct formation … The preference of cisplatin’s
affinity towards guanine at the N7… Cisplatin binds to mitochondrial DNA as well leading to cell

[HTML][HTML] Cisplatin in liver cancer therapy

S Hamaya, K Oura, A Morishita, T Masaki - International Journal of …, 2023 - mdpi.com
… Platinum atoms bind preferentially to the nitrogen atom at … TATA box and the cisplatin-DNA
adduct. Consequently, this … toxin and damages nuclear and mitochondrial DNA, causing ROS …

Beyond base excision repair: an evolving picture of mitochondrial DNA repair

K Allkanjari, RA Baldock - Bioscience Reports, 2021 - portlandpress.com
… , mtDNA loss or a decrease in the number of functional copies of the mitochondrial genome
… of POLβ versus POLγ in gap filling correlates with preference for either short-patch or long-…

Redox resetting of cisplatin-resistant ovarian cancer cells by cisplatin-encapsulated nanostructured lipid carriers

D Mittal, L Biswas, AK Verma - Nanomedicine, 2021 - Taylor & Francis
… translesion DNA synthesis, and an increase in nucleotide excisionLess prominent is the fact
that mitochondrial DNA (mtDNA) … mtDNA adducts possibly interferes with the transcription of …